Cho Y, Kim S, Kim P, Jo M, Park S, Choi Y
Biomolecules. 2025; 15(2).
PMID: 40001594
PMC: 11852853.
DOI: 10.3390/biom15020291.
Qiu T, Fu O
Front Mol Neurosci. 2025; 18:1536577.
PMID: 39974186
PMC: 11835808.
DOI: 10.3389/fnmol.2025.1536577.
Patel T, Jun J, Seo A, Levi N, Elizondo D, Chen J
Nat Commun. 2025; 16(1):1690.
PMID: 39956805
PMC: 11830824.
DOI: 10.1038/s41467-025-56936-1.
Possa-Paranhos I, Butts J, Pyszka E, Nelson C, Congdon S, Cho D
J Physiol. 2024; 603(2):379-410.
PMID: 39718394
PMC: 11737543.
DOI: 10.1113/JP286699.
Jamaluddin A, Wyatt R, Lee J, Dowsett G, Tadross J, Broichhagen J
bioRxiv. 2024; .
PMID: 39574659
PMC: 11580913.
DOI: 10.1101/2024.11.06.622243.
Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).
Weirath N, Haskell-Luevano C
ACS Pharmacol Transl Sci. 2024; 7(9):2706-2724.
PMID: 39296259
PMC: 11406693.
DOI: 10.1021/acsptsci.4c00129.
Alx3 deficiency disrupts energy homeostasis, alters body composition, and impairs hypothalamic regulation of food intake.
Mirasierra M, Fernandez-Perez A, Lizarbe B, Keiran N, Ruiz-Canas L, Casarejos M
Cell Mol Life Sci. 2024; 81(1):343.
PMID: 39129011
PMC: 11335267.
DOI: 10.1007/s00018-024-05384-z.
Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice.
Dahir N, Gui Y, Wu Y, Sweeney P, Rouault A, Williams S
J Clin Invest. 2024; 134(14).
PMID: 39007271
PMC: 11245150.
DOI: 10.1172/JCI178250.
Neuroanatomical dissection of the MC3R circuitry regulating energy rheostasis.
Possa-Paranhos I, Butts J, Pyszka E, Nelson C, Cho D, Sweeney P
bioRxiv. 2024; .
PMID: 38712101
PMC: 11071362.
DOI: 10.1101/2024.04.22.590573.
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic....
Ericson M, Freeman K, Larson C, Bouchard J, John K, Lunzer M
ACS Pharmacol Transl Sci. 2024; 7(4):1114-1125.
PMID: 38633589
PMC: 11020072.
DOI: 10.1021/acsptsci.4c00011.
Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides.
Strnadova V, Pacesova A, Charvat V, Smotkova Z, Zelezna B, Kunes J
Biosci Rep. 2024; 44(4).
PMID: 38577975
PMC: 11043025.
DOI: 10.1042/BSR20231385.
Cloning, distribution, and effects of growth regulation of MC3R and MC4R in red crucian carp ( red var.).
Huang L, Deng X, Yang X, Tang Z, Fan S, Zhou Z
Front Endocrinol (Lausanne). 2024; 14:1310000.
PMID: 38322156
PMC: 10846643.
DOI: 10.3389/fendo.2023.1310000.
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity.
Gan H, Cerbone M, Dattani M
Endocr Rev. 2023; 45(3):309-342.
PMID: 38019584
PMC: 11074800.
DOI: 10.1210/endrev/bnad033.
Deficiency of apoA-IV in Female 129X1/SvJ Mice Leads to Diet-Induced Obesity, Insulin Resistance, and Decreased Energy Expenditure.
Qu J, Wu D, Ko C, Zhu Q, Liu M, Tso P
Nutrients. 2023; 15(21).
PMID: 37960308
PMC: 10650794.
DOI: 10.3390/nu15214655.
Melanocortin-3 receptor expression in AgRP neurons is required for normal activation of the neurons in response to energy deficiency.
Gui Y, Dahir N, Wu Y, Downing G, Sweeney P, Cone R
Cell Rep. 2023; 42(10):113188.
PMID: 37792535
PMC: 10728878.
DOI: 10.1016/j.celrep.2023.113188.
Lipocalin 2 receptors: facts, fictions, and myths.
Schroder S, Gasterich N, Weiskirchen S, Weiskirchen R
Front Immunol. 2023; 14:1229885.
PMID: 37638032
PMC: 10451079.
DOI: 10.3389/fimmu.2023.1229885.
The Parallel Structure-Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands.
Ericson M, Freeman K, Lavoi T, Donow H, Santos R, Giulianotti M
Int J Mol Sci. 2023; 24(12).
PMID: 37373293
PMC: 10299128.
DOI: 10.3390/ijms241210145.
Evaluation of the MC3R gene pertaining to body weight and height regulation and puberty development.
Zheng Y, Rajcsanyi L, Peters T, Dempfle A, Wudy S, Hebebrand J
Sci Rep. 2023; 13(1):10419.
PMID: 37369769
PMC: 10300021.
DOI: 10.1038/s41598-023-37344-1.
Targeting the central melanocortin system for the treatment of metabolic disorders.
Sweeney P, Gimenez L, Hernandez C, Cone R
Nat Rev Endocrinol. 2023; 19(9):507-519.
PMID: 37365323
DOI: 10.1038/s41574-023-00855-y.
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH].
Ericson M, Tran L, Mathre S, Freeman K, Holdaway K, John K
J Med Chem. 2023; 66(12):8103-8117.
PMID: 37307241
PMC: 10631449.
DOI: 10.1021/acs.jmedchem.3c00432.